Brandon Dairo
Interventional Pain Medicine · San Diego, CANPI 1689092470
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,138 of the $10,573 with a category attached, or 77.0%. 27 manufacturers reported payments, led by Abbott at 32.1% of the total. Reporting peaked in 2019 at $3,422 and has fallen 81.5% since, to $633 in 2025.
Across 246 payments — averaging $42.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$2K
- Spinal Simplicity, LLC$2K
- Nevro Corp.$819
- Merz North America, Inc.$445
- Medtronic$440
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$70%
- Travel & lodging$7988%
- Food & beverage$8,13877%
- Education$1,62915%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 88 | $3,395 |
| Boston Scientific | 65 | $2,309 |
| Spinal Simplicity, LLC | 5 | $1,835 |
| Nevro Corp. | 24 | $819 |
| Merz North America, Inc. | 6 | $445 |
| Medtronic(2 entities) | 9 | $440 |
| Vertiflex, Inc. | 7 | $242 |
| Si-bone, Inc. | 3 | $235 |
| Biotronik NRO, Inc. | 4 | $181 |
| Collegium Pharmaceutical, Inc. | 7 | $107 |
| Nalu Medical, Inc. | 5 | $94 |
| Stryker | 2 | $66 |
| Painteq LLC | 2 | $62 |
| GRT US Holding, Inc. | 2 | $48 |
| Vertos Medical, Inc. | 1 | $43 |
| Arbor Pharmaceuticals, Inc. | 3 | $41 |
| Zyla Life Sciences, Inc. | 2 | $37 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Pacira Therapeutics, Inc. | 1 | $19 |
| Vision Quest Industries Inc. | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Averitas Pharma Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $13 |
| Forte Bio-pharma LLC | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
| Sentynl Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,573 in reported general payments places this provider in the 75th percentile of 188 interventional pain medicine providers in California.
See all interventional pain medicine providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 70 | $3,279 |
| Celecoxib | 30 | $1,806 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $994 |
| Diclofenac Sodium | 34 | $802 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $781 |
| Gabapentin | 54 | $647 |
| Ibuprofen | 23 | $202 |
| Duloxetine Hcl | 16 | $172 |
| Cyclobenzaprine Hcl | 16 | $166 |
| Naproxen | 13 | $99 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in San Diego
- Brandon VannoordSan Diego$15K
- Michael MoonSan Diego$7K
- Roy BrownlowSan Diego$6K
- Michael Verdolinla Mesa$507K
- Tim LeierRancho Mirage$449K
- Jonathan GrossmanVisalia$404K
- Kasra MaasumiRancho Santa Margarita$388K
- Andrew GermanovichRancho Mirage$333K
- David LeeYorba Linda$257K
- Standiford HelmOrange$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.